Sandeep Jagtap: Presenting the Research Behind Pediatric Fondaparinux at ISTH 2026
Sandeep Jagtap, Senior Director, Global Clinical Strategy and Innovation at Viatris, shared a post on LinkedIn:
“Some scientific moments stay with you for a long time.
It was truly special to present one of our most cherished pieces of work at ISTH 2026 in Paris. This research on Arixtra (fondaparinux) contributed to its FDA approval for pediatric venous thromboembolism patients, helping address an area of significant unmet medical need.
Presenting this work on such a prestigious global platform was both humbling and deeply rewarding.
I am sincerely grateful to all the colleagues, investigators, and collaborators whose dedication and contributions made this work possible. It was a proud and memorable moment to see years of collective effort translated into meaningful progress for children.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients